Bullishalerts.com: Focus List Philadelphia, PA, Jul 10, 2007 (M2 PRESSWIRE via COMTEX) -- Bullish Alerts is currently monitoring the following Stocks: iFinix Corp. (OTC: INXR), Global Resource Corporation (OTC: GBRC), Upstream Biosciences Inc. (OTCBB: UPBS) and eMagin Corporation (OTC: EMAN)
For a comprehensive report please visit www.bullishalerts.com and sign up for our free investment newsletter.
iFinix Corp. (OTC: INXR) is currently trading at .0013 per share up 44.44% on 111,243,983 volume while 184 trades have been placed. On Tuesday July 10th iFinix Corp. announced it has signed a letter of intent with Legend Securities, Inc. ("Legend"), a New York City-based securities broker/dealer, Member NASD/MSRB/SIPC, to license its iFinix RealTime Information Platform. iFinix RealTime is a desktop information platform that supplies streaming quotes of the most timely and accurate pricing and volume data available for microcap stocks today.
iFinix is a diversified information technology services and solutions company with expertise in systems integration, outsourcing, infrastructure and server technology. iFinix has established a product line that delivers financial and business information with streaming, real-time market data, news and analytics to professionals and active individual investors. The company's suite of products includes iFinix RealTime, iFinix Trader and eFinix.
Global Resource Corporation (OTC: GBRC) is currently trading at 2.80 per share down 3.4% on 60,465 volume while 81 trades have been placed. On Monday July 9th Global Resource Corporation announced the results from tests proving that the Company's energy conversion process can produce oil and vast amounts of combustible gas from recycled plastics. Global Resource's chief engineer, Hawk Hogan, revealed the results, from tests performed in the Company's laboratory, during Recycling Today Magazine's 'Plastics Recycling Conference' in Orlando. Mr. Hogan introduced the world's most efficient and high-yield plastics-to-energy conversion process, designed by Global Resource, to representatives of global recycling companies.
Global Resource Corp. has a patent pending process that allows for removal of oil and alternative petroleum products at very low cost from various resources, including shale deposits, tar sands, waste oil streams and bituminous coal with significantly greater yields and lower costs than are available utilizing existing known technologies. The process uses specific frequencies of microwave radiation to extract oils and alternative petroleum products from secondary raw materials, and is expected to dramatically reduce the cost for oil and gas recovery from a variety of unconventional hydrocarbon resources. GBRC's technology will not only be developed to extract oil from shale, but from depleted oil fields in the US and elsewhere, many of which still contain more than half of the hydrocarbons originally in these fields, because the residual hydrocarbons are too viscous to extract with conventional technology.
Upstream Biosciences Inc. (OTCBB: UPBS) is currently trading at .87 per share up 27.27% on 372,983 volume while 89 trades have been placed. On Tuesday July 10th Upstream Biosciences Inc. announced that it has retained Genpathway, Inc. to conduct analysis using its highly sensitive chromatin immunoprecipitation assays. The analysis is intended to provide critical information for the next phase of Upstream's program to validate its first two cancer biomarkers and drug response assay. Genpathway will apply its assays to help elucidate critical parameters involving specific gene transcription factors and pathways.
Upstream is developing diagnostic tests designed to aid in the early detection of cancer by identifying individuals with a high degree of susceptibility to the disease. The company is also developing genetic-based diagnostic tests to measure how individuals respond to specific drugs, enabling physicians to determine beforehand whether a therapy will be useful or harmful to the patient. A recent study in the Journal of the American Medical Association estimated that each year about 100,000 people die in the United States due to adverse reactions to prescription drugs.
eMagin Corporation (OTC: EMAN) is currently trading at 1.11 per share up 23.3% on 143,982 volume while 86 trades have been placed. On Tuesday July 10th eMagin Corporation has revised its guidance upward for the second quarter and issued guidance for the full fiscal year. The company now projects revenues of $4.2 million for the second quarter and estimates annual revenues of more than $16 million. At the same time, the company has issued new software that will enable users of its Z800 3DVisor to save application-specific settings and even create a virtual desktop that accommodates multiple windows.
A leader in OLED microdisplay technology and personal display systems, eMagin integrates high-resolution OLED microdisplays with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin microdisplays provide near-eye imagery in a variety of products from military, industrial, medical and consumer OEMs. The company's own Z800 3DVisor provides 3D stereovision and headtracking for PC gaming, training and simulation, immersion therapy, and other applications. eMagin's microdisplay manufacturing and R&D operations are co-located with IBM on its campus in East Fishkill, New York. System design facilities and sales and marketing are located in Bellevue, Washington.
Bullish Alerts www.bullishalerts.com is a division of Main Line Capital Group, LLC - www.mainlinecapital.com If you would like to feature your publicly traded company in our alerts or on Bullish Alerts, email editor@bullishalerts.com
